Obstetrics and Gynaecology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Gynaecological Oncology, Gloucestershire Hospitals NHS Foundation Trust, Cheltenham, UK.
BMJ Open Qual. 2022 May;11(2). doi: 10.1136/bmjoq-2021-001709.
In 2018, cervical screening uptake was at its lowest level since screening began, particularly in those aged 25-35, coinciding with the peak incidence of cervical cancer and average age at first delivery.
Retrospective baseline data of pregnant women found 47.3% (n=123/260) were overdue for screening by delivery, of whom 74% (n=91/123) remained overdue by 6 months postnatal.
We undertook a quality improvement project from April 2018 to April 2019 to improve cervical screening uptake in pregnant and postnatal women. We mapped out the screening process and canvassed stakeholders. The main theme was inconsistency of advice received by women. From February 2018 to May 2020, we undertook a prospective audit of 10 women per week who gave birth in our maternity department, recording screening status at delivery and 6 months postnatal.Interventions included introducing evidence-based guidelines about cervical screening in pregnancy and the postnatal period, flow charts for maternity staff, multiprofessional teaching for all maternity staff and information dissemination to women (via the HANDiApp platform, a social media campaign and adapting results letters following colposcopy, highlighting dates when screening would be due). Primary care opening hours were extended for screening and women received a letter from their midwives, if they required cervical screening in pregnancy.
Locally, the percentage of women overdue for cervical screening by 6 months postnatal improved by 8.0% during this project, compared with a 1.6% change in national screening rates in women aged 25-49.
We increased the percentage of local pregnant and postnatal women attending cervical screening by introduction of a package of information, targeted education and widening access to screening appointments.
2018 年,宫颈癌筛查参与率降至开始筛查以来的最低水平,尤其是 25-35 岁年龄段人群,而这一年龄段正是宫颈癌发病率最高和首次分娩年龄的平均水平。
对孕妇的回顾性基线数据进行分析发现,47.3%(n=123/260)在分娩时已错过筛查,其中 74%(n=91/123)在产后 6 个月仍未进行筛查。
我们于 2018 年 4 月至 2019 年 4 月开展了一项质量改进项目,以提高孕妇和产后妇女的宫颈癌筛查参与率。我们梳理了筛查流程并对利益相关者进行了调查。主要问题是妇女获得的建议不一致。从 2018 年 2 月至 2020 年 5 月,我们对每周在我院分娩的 10 名妇女进行了前瞻性审核,记录其分娩时和产后 6 个月的筛查状况。干预措施包括引入有关孕期和产后宫颈癌筛查的循证指南、为产科工作人员制定流程图、对所有产科工作人员进行多专业教学以及向妇女宣传(通过 HANDiApp 平台、社交媒体活动和改编阴道镜检查结果信,突出提示需要进行筛查的日期)。扩大了初级保健的筛查开放时间,如果孕妇需要在孕期进行宫颈癌筛查,其将收到助产士的来信。
在该项目期间,与全国 25-49 岁女性宫颈癌筛查率的 1.6%变化相比,本地产后 6 个月内错过宫颈癌筛查的女性比例提高了 8.0%。
通过引入一整套信息、有针对性的教育和扩大筛查预约机会,我们提高了本地孕妇和产后妇女接受宫颈癌筛查的比例。